You are required to be logged in to access the full website
Click here if you have forgotten your username or password
30 April 2026 - Cell therapy company Curocell (KOSDAQ:372320) announced on Thursday that RIMQARTO Inj. (anbalcabtagene autoleucel) has received full regulatory approval from South Korea's Ministry of Food and Drug Safety, marking the first comme...
30 April 2026 - Swedish biosimilars developer Xbrane Biopharma AB (STO:XBRANE) said on Thursday that it has resubmitted its Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for its biosimilar candidate to LUCENTIS (ran...
30 April 2026 - TIME magazine has named women's health specialist Sprout Pharmaceuticals among 10 organisations globally shaping the future of health and life sciences.This recognition follows a defining period of momentum for Sprout and its fla...
30 April 2026 - US biopharmaceutical company Neurocrine Biosciences Inc (Nasdaq:NBIX) announced on Wednesday the publication of new peer-reviewed research in The Journal of Clinical Psychiatry, demonstrating how the Tardive Dyskinesia Impact Scale he...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe